Evaluation of Immature Neutrophil Ratio and Calprotectin Level for the Diagnosis of Neonatal Sepsis


1 Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Department of Pediatrics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran


Background: Sepsis is defined as a systematic inflammatory reaction against infection. Despite the recent advances in medical and pediatric sciences, sepsis remains a significant life-threatening health issue. The main problem associated with this disorder is the nonspecific and non-discriminative symptoms of noninfectious diseases. The present study aimed to introduce diagnostic parameters of high sensitivity and specificity for neonatal sepsis.
Methods: This case-control study was conducted in Mashhad, Iran during 2013-2015. Subjects included 40 septic neonates with confirmed diagnosis by a subspecialist of pediatrics and 40 neonates without clinical and laboratory findings of sepsis as the control group. Blood samples were collected from all the infants. In addition, differential white blood cell count of peripheral blood smear was performed, and immature/total neutrophil ratio (I/T) was calculated for all the PBS slides. Plasma calprotectin levels were also determined using the sandwich ELISA method.
Results: Mean plasma concentration of calprotectin was 33190±23760 and 18980±13410 ng/ml in the septic and control groups, respectively. Moreover, mean I/T was 0.61±0.22 and 0.51±0.26 in the septic and control groups, respectively. The obtained results indicated that calprotectin levels and I/T were significantly higher in the septic group compared to the control group (P<0.05). Conclusion: According to the results, nucleated red blood cell count and calprotectin levels were the most specific parameters for the definite diagnosis of neonatal sepsis, while neutrophils had the highest sensitivity in this regard


1. Arif SA, Ehsan A, Arif M, Hussain J, Bano R. Early diagnosis of neonatal sepsis through hematological and biochemical markers. Gomal J Med Sci. 2014; 11(2):178-82.

 2. Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock. 2013; 40(5):358-65.

3. Umlauf VN, Dreschers S, Orlikowsky TW. Flow cytometry in the detection of neonatal sepsis. Int J Pediatr. 2013; 2013:1-6.

4. Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013; 60(2):367-89.

 5. Bhandari V. Effective biomarkers for diagnosis of neonatal sepsis. J Pediatr Infect Dis Soc. 2014; 3(3):234-45.

 6. Resch B, Hofer N, Müller W. Challenges in the diagnosis of sepsis of the neonate: New York: Open Access Publisher; 2012.

7. Singh Laishram R, Devi Khuraijam R. Hematological and biological markers of neonatal sepsis. Iran J Pathol. 2013; 8(3):137-46.

 8. Mussap M. Laboratory medicine in neonatal sepsis and inflammation. J Matern Fetal Neonatal Med. 2012; 25(Suppl 4):32-4.

9. van Herk W, El Helou S, Janota J, Hagmann C, Klingenberg C, Staub E, et al. PO-0253 use of infection markers for diagnostic and management of suspected neonatal early onset neonatal sepsis: an international survey. Arch Dis Childhood. 2014; 99(Suppl 2):A326-7.

10. Boskabad H, Moudi A, Parvini Z, Barati T. Evaluation of the cause and related factors of neonatal mortality in Qaem hospital 2010-2011. Iran J Obstet Gynecol Infertil. 2012; 14(7):21-6 (Persian). 11. Tappero E, Johnson P. Laboratory evaluation of neonatal sepsis. Newborn Infant Nurs Rev. 2010; 10(4):209-17.

 12. Sandquist M, Wong HR. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 2014 Oct;10(10):1349-56.Mally P, Xu J, Hendricks-Muñoz KD. Biomarkers for neonatal sepsis: recent developments. Res Rep Neonatol. 2014; 4:157-68.

 13. Mally P, Xu J, Hendricks-Muñoz KD. Biomarkers for neonatal sepsis: recent developments. Res Rep Neonatol. 2014; 4:157-68.

14. Satar M, Ozlü F. Neonatal sepsis: a continuing disease burden. Turk J Pediatr. 2012; 54(5):449-57.

 15. Abdel-Maaboud M, El-Mazary AA, Osman AM. Serum calprotectin as a diagnostic marker of late onset sepsis in full-term neonates. Egyp J Pediatr Allergy Immunol. 2014; 10(1):19-24.

16. Riskawa HK, Hilmanto D, Chairulfatah A. Serum calprotectin in preterm infants with and without sepsis neonatorum. J Indonesian Med Assoc. 2013; 62(4):125-9.

 17. Decembrino L, De Amici M, Pozzi M, De Silvestri A, Stronati M. Serum calprotectin: a potential biomarker for neonatal sepsis. J Immunol Res. 2015; 2015:147973.

 18. Stachon A, Bolulu O, Holland-Letz T, Krieg M. Association between nucleated red bloodcells in blood and the levels of erythropoietin, interleukin 3, interleukin 6, and interleukin 12p70. Shock. 2005; 24(1):34-9.

 19. Ferber A, Fridel Z, Weissmann-Brenner A, Minior VK, Divon MY. Are elevated fetal nucleated red blood cell counts an indirect reflection of enhanced erythropoietin activity? Am J Obstet Gynecol. 2004; 190(5):1473-5.

 20. Boskabadi H, Maamouri G, Tavakol Afshari J, Mafinejad S, Hosseini G, Mostafavi-Toroghi H, et al. Evaluation of serum interleukins-6, 8 and 10 levels as diagnostic markers of neonatal infection and possibility of mortality. Iran J Basic Med Sci. 2013; 16(12):1232-7.

21. Boskabadi H, Maamouri G, Sadeghian MH, GhayourMobarhan M, Heidarzade M, Shakeri MT, et al. Early diagnosis of perinatal asphyxia by nucleated red blood cell count: a case-control study. Arch Iran Med. 2010; 13(4):275-81.

 22. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatal. 2009; 33(3):130-7.